Orange Book product · Generic (ANDA)
CITALOPRAM HYDROBROMIDE
CITALOPRAM HYDROBROMIDE
At a glance
Dec 15, 2015
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 15, 2015
10 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CITALOPRAM HYDROBROMIDE
Strength
EQ 10MG BASE/5ML
Dosage form
SOLUTION
Route
ORAL
TE code
AA
Application
ANDA 201450
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CITALOPRAM HYDROBROMIDE
- 2022CITALOPRAM HYDROBROMIDEBrand (NDA)
NDA 215428 · ALMATICA
- 2005CITALOPRAM HYDROBROMIDEBrand (NDA)
NDA 021763 · BIOVAIL LABS INTL
- 2000CELEXABrand (NDA)
NDA 020822 · ABBVIE
- 1999CELEXABrand (NDA)
NDA 021046 · FOREST LABS
- 2026CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 219985 · AUROBINDO PHARMA LTD
- 2015CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 205407 · JUBILANT GENERICS
- 2009CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 077654 · GLENMARK PHARMS LTD
- 2008CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 077141 · NATCO PHARMA LTD
- 2007CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 078216 · TORRENT PHARMS
- 2007CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 077668 · PHARMOBEDIENT
- 2006CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 077289 · AMNEAL PHARMS NY
- 2006CITALOPRAM HYDROBROMIDEGeneric (ANDA)
ANDA 077534 · INVAGEN PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
